Smith & Nephew (SNN) Non-Current Deferred Tax Liability (2009 - 2025)

Smith & Nephew (SNN) posted quarterly Non-Current Deferred Tax Liability of $40.0 million for Q4 2025, up 29.03% year-on-year from $31.0 million in Q4 2024, and down 4.76% on a QoQ basis from $42.0 million in Q2 2025.

Smith & Nephew (SNN) Non-Current Deferred Tax Liability (2009 - 2025) Analysis & Trends

Smith & Nephew (SNN) has reported Non-Current Deferred Tax Liability for 17 consecutive years, with $40.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability rose 29.03% year-over-year to $40.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40.0 million (up 29.03% YoY) and the FY2025 annual result came in at $40.0 million, up 29.03% from the prior year.
  • Non-Current Deferred Tax Liability eased to $40.0 million in Q4 2025 per SNN's latest filing, from $42.0 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for SNN reached as high as $144.0 million in Q4 2021 and fell as low as $9.0 million in Q4 2023.
  • A 5-year average of $48.3 million and a median of $36.0 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability plunged 75.0% — and 2024, when it jumped 244.44%.
  • Year by year, Non-Current Deferred Tax Liability stood at $144.0 million in 2021, then tumbled by 75.0% to $36.0 million in 2022, then tumbled by 75.0% to $9.0 million in 2023, then soared by 244.44% to $31.0 million in 2024, then rose by 29.03% to $40.0 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $40.0 million, $42.0 million, and $31.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 40.00 Mn
Dec 31, 2025 40.00 Mn
Jun 28, 2025 42.00 Mn
Jun 28, 2025 42.00 Mn
Dec 31, 2024 31.00 Mn
Dec 31, 2024 31.00 Mn
Jun 29, 2024 36.00 Mn
Jun 29, 2024 36.00 Mn
Dec 31, 2023 9.00 Mn
Dec 31, 2023 9.00 Mn
Dec 31, 2022 36.00 Mn
Dec 31, 2022 36.00 Mn
Dec 31, 2021 144.00 Mn
Dec 31, 2021 144.00 Mn
Dec 31, 2020 141.00 Mn
Dec 31, 2020 141.00 Mn
Jun 30, 2020 163.00 Mn
Jun 30, 2020 163.00 Mn
Dec 31, 2019 167.00 Mn
Dec 31, 2019 167.00 Mn